Iberogast (Milk Thistle Fruit Extract, Bitter Candytuft Fresh Plant Extract, Matricaria Liquid Extract, Menthae)

Iberogast combines several plant extracts that act together to relax gastrointestinal smooth muscle, promote coordinated motility and dampen inflammatory signals. The mixture influences calcium channel activity and visceral sensory pathways, providing spasmolytic, pro‑kinetic and anti‑inflammatory effects that improve gut function.

The appropriate dose of Iberogast is determined by the prescribing healthcare professional based on the individual’s condition, age and response. Patients should follow the specific instructions provided on the product label or by their clinician and not exceed the recommended amount.

Safety data for Iberogast in pregnancy and lactation are limited. It is generally advised to avoid use unless the potential benefit justifies the possible risk. Women who are pregnant, planning a pregnancy or breastfeeding should discuss alternatives with their healthcare provider.

To order Iberogast, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The primary alternative to Iberogast is conventional pro‑kinetic or antispasmodic medication such as domperidone or mebeverine. Unlike single‑molecule drugs, Iberogast offers a multi‑component herbal approach that may provide broader symptom relief with a different safety profile, but comparative efficacy varies among individuals.

Iberogast should be stored at ambient temperature, preferably below 25 °C, in its original container. Protect the suspension from moisture, direct sunlight and extreme temperature fluctuations. Keep the bottle tightly closed when not in use to maintain product stability.

Iberogast is taken orally as a liquid suspension. The patient measures the prescribed amount using the provided dosing device and swallows it directly or mixes it with a small amount of water, according to the instructions given by the prescriber.

The most serious risks include severe allergic reactions such as anaphylaxis and rare cases of liver injury (hepatotoxicity). Patients should seek immediate medical attention if they experience symptoms like rash, swelling, difficulty breathing, jaundice or persistent abdominal pain.

Iberogast should be avoided by individuals with known hypersensitivity to any of its plant extracts, those with severe liver disease, and patients taking medications that may interact dangerously, such as certain anticoagulants or anticholinergic agents, without medical supervision.